Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

33
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
33
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

41
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
41
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

29
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
29
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

29
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
29
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

28
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
28
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

119
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
119

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Stage-Specific Progression of Cardiovascular-Kidney-Metabolic Health and Mortality in a Nationwide Cohort of East Asian Adults.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Timing of urate-lowering therapy and risk of kidney failure and mortality in CKD: an application of the parametric G-formula.

Clinical kidney journal·2026
Same author

Intra-individual fluctuations in alkaline phosphatase predict mortality and CKD progression: insights from a large CKD cohort.

Clinical kidney journal·2026
Same author

Systemic Proteome Profiling to Differentiate Primary Glomerular Diseases.

Journal of the American Society of Nephrology : JASN·2026
Same author

Causal Effect of Kidney Function on Lipid Metabolism: An Integrated Population-Scale Observational Analysis and Mendelian Randomization Study.

Kidney medicine·2026
Same author

Heterogeneous Kidney Patterns in Diabetic Patients Following SGLT2 Inhibitor Use.

Journal of Korean medical science·2026

相关实验视频

Updated: Jul 16, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

687

原发性硬化性胆道炎因果影响功能下降:孟德尔的随机化研究.

Jeong Min Cho1, Jung Hun Koh1, Seong Geun Kim2

  • 1Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.

Journal of gastroenterology and hepatology
|September 20, 2023
PubMed
概括

原发性硬化性胆道炎 (PSC) 与功能受损有因果关系,包括估计膜过率 (eGFR) 降低和慢性病 (CKD) 风险增加. 这项研究强调了PSC和有害脏结果之间的显著关联.

关键词:
慢性功能衰竭 慢性功能衰竭淋巴细胞的过率是什么功能测试是功能测试.门德尔的随机化分析.原发性硬化性胆管炎的发生.

更多相关视频

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

11.5K
Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

15.7K

相关实验视频

Last Updated: Jul 16, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

687
Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

11.5K
Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

15.7K

科学领域:

  • 遗传学 是一个遗传学.
  • 腎臟病學 (nephrology) 是一種醫學專業.
  • 胃肠病学 胃肠病学

背景情况:

  • 原发性硬化性胆道炎 (PSC) 和功能之间的关系在很大程度上仍未被探索.
  • 无论是PSC还是功能障碍,都可能导致长期的健康并发症.

研究的目的:

  • 使用孟德尔的随机化方法调查PSC和功能之间的潜在因果关系.
  • 评估PSC与关键功能参数 (如eGFR,eGFR下降和CKD) 之间的关联.

主要方法:

  • 一项两样本的门德尔随机化 (MR) 研究利用了PSC GWAS的遗传变异和CKDGen联盟的功能数据.
  • 遗传关联分析包括多重随机效应逆变量加权 (MR-IVW) 和类强方法.
  • 分析的关键功能特征是估计的淋巴细胞过率 (eGFR),每年eGFR下降和慢性病 (CKD).

主要成果:

  • 基因预测的PSC显示与功能受损有显著的因果关系.
  • PSC与日志转化EGFR (β = -0.41%,P < 0.001) 的降低有关.
  • 此外,PSC还与每年EGFR下降的增加有关 (β = 2.43%,P < 0.001) 以及患CKD的风险更高 (OR = 1.07,P < 0.001).

结论:

  • 遗传预测的PSC与功能障碍有因果关系.
  • 这些发现表明PSC可能会对脏健康产生负面影响.
  • 需要进一步的研究来阐明这种关联背后的具体机制.